What’s Ahead for Melanoma Management

Source: Dermatology Times, May 2022

Immunotherapy, intralesional treatments, multidisciplinary care teams define rapidly-evolving multimodal approach.

Key directions for melanoma treatments under development include treating tumors in the perioperative period and addressing unresectable tumors, according to a review published in Oral and Maxillofacial Surgery Clinics of North America.1 This rapidly evolving environment will require physicians to monitor evolving care standards and embrace multidisciplinary teamwork, authors added.

“Even though we’ve had profound success in terms of melanomas treatment in the last 10 years, we’ve also seen a cemetery of failed ideas and failed treatments, most of which involve the immune system,” corresponding author James R. Nitzkorski, MD, told Dermatology Times®. He is a surgical oncologist and director of the surgical residency training program at Nuvance Health, Vassar Brothers Medical Center, in Poughkeepsie, New York.

READ THE ORIGINAL FULL ARTICLE